Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn’s Disease in Korea: Results from the CONNECT Study

키워드

참고문헌 (47)

1. 김은수, "Inflammatory Bowel Disease in Korea: Epidemiological, Genomic, Clinical, and Therapeutic Characteristics", Gut and Liver, 4(1), pp.1~14 (2010), 거트앤리버 소화기연관학회협의회
2. 유수현, "Fatigue Severity and Factors Associated with High Fatigue Levels in Korean Patients with Inflammatory Bowel Disease", Gut and Liver, 8(2), pp.148~153 (2014), 거트앤리버 소화기연관학회협의회
3. 이승훈, "Immunological pathogenesis of inflammatory bowel disease", Intestinal research, 16(1), pp.26~42 (2018), 대한장연구학회
4. 김영선, "Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases", Intestinal research, 15(3), pp.338~344 (2017), 대한장연구학회
5. Abraham C, "Inflammatory bowel disease", N Engl J Med, 361, pp.2066~2078 (2009)[DOI]
6. Knights D, "Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome", Gut, 62, pp.1505~1510 (2013)[DOI]
7. Hiroko Nagao-Kitamoto, "Pathogenic role of the gut microbiota in gastrointestinal diseases", Intestinal research, 14(2), pp.127~138 (2016), 대한장연구학회
8. Chen-Wang Chang, "Intestinal Stricture in Crohn’s Disease", Intestinal research, 13(1), pp.19~26 (2015), 대한장연구학회[DOI]
9. Thia KT, "An update on the epidemiology of inflammatory bowel disease in Asia", Am J Gastroenterol, 103, pp.3167~3182 (2008)[DOI]
10. Hugot JP, "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease", Nature, 411, pp.599~603 (2001)[DOI]
11. Ogura Y, "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease", Nature, 411, pp.603~606 (2001)[DOI]
12. Croucher PJ, "Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations", Eur J Hum Genet, 11, pp.6~16 (2003)[DOI]
13. Inoue N, "Lack of common NOD2 variants in Japanese patients with Crohn's disease", Gastroenterology, 123, pp.86~91 (2002)[DOI]
14. Guo QS, "NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality", World J Gastroenterol, 10, pp.1069~1071 (2004)[DOI]
15. Yang SK, "Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study", Inflamm Bowel Dis, 14, pp.542~549 (2008)[DOI]
16. Oriuchi T, "Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality", J Gastroenterol, 38, pp.942~953 (2003)[DOI]
17. 임종필, "Adalimumab or infliximab: which is better for perianal fistula in Crohn’s disease?", Intestinal research, 15(2), pp.147~148 (2017), 대한장연구학회
18. Jin Young Yoon, "Effects of Perianal Involvement on Clinical Outcomes in Crohn’s Disease over 10 Years", Gut and Liver, 12(3), pp.297~305 (2018), 거트앤리버 소화기연관학회협의회
19. Ingle SB, "The natural history of perianal Crohn's disease", Dig Liver Dis, 39, pp.963~969 (2007)[DOI]
20. 천재희, "Crohn’s Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn’s Disease in Korea", Intestinal research, 12(3), pp.173~175 (2014), 대한장연구학회
21. Jung YS, "Long-term clinical outcomes of urban versus rural environment in Korean patients with Crohn's disease: results from the CONNECT study", J Crohns Colitis, 9, pp.246~251 (2015)[DOI]
22. Moon CM, "Clinical factors and disease course related to diagnostic delay in Korean Crohn's disease patients: results from the CONNECT Study", PLoS One, 10, pp.e0144390~ (2015)[DOI]
23. Kim B, "Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study", J Gastroenterol Hepatol, 31, pp.126~132 (2016)[DOI]
24. Doh YS, "The clinical characteristics of patients with free perforation in Korean Crohn's disease: results from the CONNECT study", BMC Gastroenterol, 15, pp.31~ (2015)[DOI]
25. 김남희, "Long-Term Clinical Outcomes of Korean Patient With Crohn’s Disease Following Early Use of Infliximab", Intestinal research, 12(4), pp.281~286 (2014), 대한장연구학회
26. Satsangi J, "The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications", Gut, 55, pp.749~753 (2006)[DOI]
27. Kamm MA, "Perianal fistulizing Crohn's disease: a call to action", Clin Gastroenterol Hepatol, 6, pp.7~10 (2008)[DOI]
28. Henckaerts L, "Genetic risk profiling and prediction of disease course in Crohn's disease patients", Clin Gastroenterol Hepatol, 7, pp.972~980 (2009)[DOI]
29. Yoneno K, "Risk and management of intra-abdominal abscess in Crohn's disease treated with infliximab", Digestion, 89, pp.201~208 (2014)[DOI]
30. Tang LY, "Are perineal and luminal fistulas associated in Crohn's disease? A population-based study", Clin Gastroenterol Hepatol, 4, pp.1130~1134 (2006)[DOI]
31. Sachar DB, "Is perianal Crohn's disease associated with intestinal fistulization", Am J Gastroenterol, 100, pp.1547~1549 (2005)[DOI]
32. Cosnes J, "Long-term evolution of disease behavior of Crohn's disease", Inflamm Bowel Dis, 8, pp.244~250 (2002)[DOI]
33. Thia KT, "Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort", Gastroenterology, 139, pp.1147~1155 (2010)[DOI]
34. Gelbmann CM, "Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease", Am J Gastroenterol, 97, pp.1438~1445 (2002)[DOI]
35. Beaugerie L, "Predictors of Crohn's disease", Gastroenterology, 130, pp.650~656 (2006)[DOI]
36. Lapidus A, "Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients", Gastroenterology, 114, pp.1151~1160 (1998)[DOI]
37. Han YM, "Patients with perianal Crohn's disease have poor disease outcomes after primary bowel resection", J Gastroenterol Hepatol, 31, pp.1436~1442 (2016)[DOI]
38. Ji Won Kim, "Results of the first survey for the current status of inflammatory bowel disease management in Asian countries", Intestinal research, 14(3), pp.199~201 (2016), 대한장연구학회
39. American Gastroenterological Association Clinical Practice Committee, "American Gastroenterological Association medical position statement: perianal Crohn's disease", Gastroenterology, 125, pp.1503~1507 (2003)[DOI]
40. Ye BD, "Clinical features and long-term prognosis of Crohn's disease in Korea", Scand J Gastroenterol, 45, pp.1178~1185 (2010)[DOI]
41. Hellers G, "Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease", Gut, 21, pp.525~527 (1980)[DOI]
42. Lapidus A, "Crohn's disease in Stockholm County during 1990-2001: an epidemiological update", World J Gastroenterol, 12, pp.75~81 (2006)[DOI]
43. Schwartz DA, "The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota", Gastroenterology, 122, pp.875~880 (2002)[DOI]
44. Moon CM, "Clinical features and predictors of clinical outcomes in Korean patients with Crohn's disease: a Korean association for the study of intestinal diseases multicenter study", J Gastroenterol Hepatol, 29, pp.74~82 (2014)[DOI]
45. Wee Khoon Ng, "Changing epidemiological trends of inflammatory bowel disease in Asia", Intestinal research, 14(2), pp.111~119 (2016), 대한장연구학회
46. Zallot C, "Clinical risk factors for complicated disease: how reliable are they", Dig Dis, 30(Suppl 3), pp.67~72 (2012)[DOI]
47. 양동훈, "Usefulness of C-Reactive Protein as a Disease Activity Marker in Crohn’s Disease according to the Location of Disease", Gut and Liver, 9(1), pp.80~86 (2015), 거트앤리버 소화기연관학회협의회

관련 논문AI추천